National Clinician Scholar's Program, Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor.
Center for Healthcare Outcomes and Policy, University of Michigan, Ann Arbor.
JAMA Netw Open. 2024 Jun 3;7(6):e2414354. doi: 10.1001/jamanetworkopen.2024.14354.
Concern has been raised about persistent sex disparities after coronary artery bypass grafting, with female patients having higher mortality. However, whether these disparities persist across hospitals of different qualities is unknown.
To evaluate sex disparities in 30-day mortality after coronary artery bypass grafting across high- and low-quality hospitals.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional, retrospective cohort study evaluated Medicare beneficiaries undergoing coronary artery bypass grafting between October 1, 2015, and March 31, 2020. Data analysis was performed from July 1, 2023, to December 1, 2023.
The primary exposures were hospital quality and sex. For hospital quality, hospitals were placed into rank order by their overall risk-adjusted mortality rate and divided into quintiles.
Risk-adjusted 30-day mortality using a logistic regression model accounting for patient factors, including sex, age, comorbidities, elective vs unplanned admission, number of bypass grafts, use of arterial graft, and year of surgery.
A total of 444 855 beneficiaries (mean [SD] age, 71.5 [7.5] years; 120 333 [27.1%] female and 324 522 [72.9%] male) were studied. Compared with male beneficiaries, female beneficiaries were more likely to have an unplanned admission (66 425 [55.2%] vs 157 895 [48.7%], P < .001) and receive care at low-quality (vs high-quality) hospitals (odds ratio, 1.26; 95% CI, 1.23-1.29; P < .001). Overall, risk-adjusted female mortality was 4.24% (95% CI, 4.20%-4.27%), and male mortality was 2.75% (95% CI, 2.75%-2.77%), with an absolute difference of 1.48 (95% CI, 1.45-1.51) percentage points (P < .001). At the highest-quality hospitals, male mortality was 1.57% (95% CI, 1.56%-1.59%), and female mortality was 2.58% (95% CI, 2.54%-2.62%), with an absolute difference of 1.01 (95% CI, 0.97-1.04) percentage points (P < .001). At the lowest-quality hospitals, male mortality was 4.94% (95% CI, 4.88%-5.01%), and female mortality was 7.02% (95% CI, 6.90%-7.13%), with an absolute difference of 2.07 (95% CI, 1.95-2.19) percentage points (P < .001). Female beneficiaries receiving care at low-quality hospitals had a higher mortality than male beneficiaries receiving care at the high-quality hospitals (7.02% vs 1.57%, P < .001).
In this cohort study of Medicare beneficiaries undergoing coronary artery bypass grafting, female beneficiaries were more likely to receive care at low-quality hospitals, where the sex disparity in mortality was double that of high-quality hospitals. Quality improvement targeting low-quality hospitals as well as equitable referral of female beneficiaries to higher-quality hospitals may narrow the sex disparity after coronary artery bypass grafting.
人们对冠状动脉旁路移植术后持续存在的性别差异表示担忧,女性患者的死亡率更高。然而,这些差异是否在不同质量的医院中持续存在尚不清楚。
评估在高、低质量医院中,冠状动脉旁路移植术后 30 天死亡率的性别差异。
设计、设置和参与者:这项回顾性队列研究纳入了 2015 年 10 月 1 日至 2020 年 3 月 31 日期间接受冠状动脉旁路移植术的 Medicare 受益人群。数据分析于 2023 年 7 月 1 日至 2023 年 12 月 1 日进行。
主要暴露因素是医院质量和性别。对于医院质量,将医院按照其整体风险调整死亡率进行排序,并分为五分位数。
使用考虑患者因素(包括性别、年龄、合并症、计划性与非计划性入院、旁路移植术数量、动脉移植物使用和手术年份)的逻辑回归模型评估风险调整后的 30 天死亡率。
共纳入 444855 名受益人群(平均[标准差]年龄为 71.5[7.5]岁;120333 名[27.1%]女性和 324522 名[72.9%]男性)。与男性受益人群相比,女性受益人群更有可能非计划性入院(66425 名[55.2%]与 157895 名[48.7%],P<0.001),并且更有可能在低质量(而非高质量)医院接受治疗(比值比,1.26;95%CI,1.23-1.29;P<0.001)。总体而言,风险调整后的女性死亡率为 4.24%(95%CI,4.20%-4.27%),男性死亡率为 2.75%(95%CI,2.75%-2.77%),绝对差值为 1.48(95%CI,1.45%-1.51)个百分点(P<0.001)。在质量最高的医院中,男性死亡率为 1.57%(95%CI,1.56%-1.59%),女性死亡率为 2.58%(95%CI,2.54%-2.62%),绝对差值为 1.01(95%CI,0.97%-1.04)个百分点(P<0.001)。在质量最低的医院中,男性死亡率为 4.94%(95%CI,4.88%-5.01%),女性死亡率为 7.02%(95%CI,6.90%-7.13%),绝对差值为 2.07(95%CI,1.95%-2.19)个百分点(P<0.001)。在低质量医院接受治疗的女性受益人群死亡率高于在高质量医院接受治疗的男性受益人群(7.02%比 1.57%,P<0.001)。
在这项对接受冠状动脉旁路移植术的 Medicare 受益人群的队列研究中,女性受益人群更有可能在低质量医院接受治疗,而这些医院中死亡率的性别差异是高质量医院的两倍。针对低质量医院进行质量改进,并公平地将女性受益人群转介到高质量医院,可能会缩小冠状动脉旁路移植术后的性别差异。